Krka Banned From Selling Donepezil In Norway

Ljubljana, 19 November - Krka Sverige has been banned from producing and marketing a drug containing the active ingredient donepezil. The Slovenian parent company Krka said Wednesday would challenge the temporary injunction issued by the Oslo Executive Court.